- Valeant Pharmaceuticals International stock price today and history
Please, Signup (Login) to subscribe or trade (demo)
Valeant Pharmaceuticals International stock price, VRX
Valeant Pharmaceuticals International stock chart:
Valeant Pharmaceuticals International close price: 13.59
Stock price forecast:
DOWN TO -13.39%
Total forecasts: 84
Reached: 38 (45.24%)
Total Win: 45.95 (479.32%)
No results found.
Showing 1-10 of 583 items.
|Date of Forecast||Stock Price||Target Price||Forecast Reached Date|
Valeant Pharmaceuticals International latest news:
BRIEF-Valeant appoints Arthur Shannon senior vice president, head of investor relations and communications
June 19 (Reuters) - Valeant Pharmaceuticals International
CANADA STOCKS-TSX ends higher as Valeant bounces, banks gain
TORONTO, June 8 (Reuters) - Canada's main stock index ended
higher on Thursday, helped by gains for banking stocks after the
Bank of Canada said it considers the system robust and a jump in
Valeant Pharmaceuticals after it announced an asset sale.
Valeant Pharmaceuticals Plans to Sell iNova Segment
Valeant stock jumps 8% after positive patent litigation developments
Valeant Pharmaceuticals International Inc. shares jumped 8.2% at $13.71 on Thursday after favorable developments in patent litigation over its biggest drug, Xifaxan. Xifaxan treats irritable bowel disease and has brought in nearly $1 billion a year for the company, though sales have flagged more recently. Though the court documents in question are sealed, the court record did divulge a favorable ruling for Valeant on two key issues, said EvercoreISI analyst Umer Raffat. In addition, a 30-month stay on patent litigation has been extended, he said. Valeant shares have dropped 8.4% over the last three months, compared with a 3.4% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
CANADA STOCKS-TSX dragged by banks and energy; Valeant, Home Capital surges
TORONTO, May 9 (Reuters) - Canada's main stock index fell
more than half a percent on Tuesday as bank and energy stocks
led the market lower, but Valeant Pharmaceuticals International
and Home Capital Group Inc stocks soared as
investors cheered news from the companies.
S&P 500, Nasdaq ump to intraday records on upbeat earnings
U.S. stocks on Tuesday opened at or near record levels as investors appeared heartened by upbeat earnings reports and the easing of some of the market's near-term worries. The Dow Jones Industrial Average traded 22 points, or less than 0.1%, at 21,1033, the S&P 500 index gained about 3 points, or 0.1%, at 2,401, briefly eclipsing its intraday record of 2,401.36 set on Monday, while the Nasdaq Composite Index climbed 7 points, or 0.2%, at 6,116-a new intraday record for the tech-heavy index. A measure of market volatility, the CBOE Volatility Index , fell to a roughly 23-year low on Monday and threatened to hit its lowest level in history, according to FactSet. The VIX has been closely followed because it implies to some market participants that investors may be getting too complacent about the possibility of sharp dives in equities, after a monthslong rise that has taken them to repeated record levels. Meanwhile, the 10-year Treasury note yield [BX: TMUBMUSD10Y], which moves inversely to price, was at 2.40%, around the highest level in weeks for the benchmark bond. Shares of Office Depot Inc. , Valeant Pharmaceuticals International Inc. and Marriott International Inc. were all trading higher after reporting better-than-expected quarterly results. Moves for the markets come after one big geopolitical overhang subsided over the weekend, with the French presidency won by Emmanuel Macron, viewed as a pro-market candidate. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Valeant, Sorrento Pharmaceuticals Tumble into Thursday’s 52-Week Low Club
Ackman apologizes for Valeant losses, calls bet a mistake
BOSTON (Reuters) - Billionaire hedge fund manager William Ackman has apologized to clients for betting on Valeant Pharmaceuticals International Inc , telling them he was "deeply and profoundly sorry"...
Valero Energy CorporationVLO
Valero Energy Partners LPVLP
Valley National BancorpVLY
Valley National BancorpVLY.WS
Valley National BancorpVLY^A
Valspar Corporation (The)VAL